Stocks
Aclarion, Inc.ACON
NASDAQHealthcareMedical Devices$1.93
Price as of · delayed, not real-time
A clinical-stage medical technology company developing a non-invasive diagnostic tool for chronic low back pain. Its flagship product, the Biomark test, uses magnetic resonance spectroscopy to identify painful discs, aiming to reduce unnecessary surgeries. Investors track ACON for its potential to disrupt the standard of care in spine diagnostics.
52W Range: $1.85-$9.36
Congressional Interest in Aclarion, Inc. (ACON)
No congressional trades have been disclosed for Aclarion, Inc. (ACON) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ACON?
No congressional trades found for this stock.